Bridging chimeric antigen receptor T-cell before transplantation improves prognosis of relapsed/refractory B-cell acute lymphoblastic leukemia.

Author: Xiangyu ZHAO ¹ ; Haotian WU ² ; Yifei CHENG ¹ ; Zhengli XU ¹ ; Yuhong CHEN ¹ ; Yingjun CHANG ¹ ; Yu WANG ¹ ; Xiaohui ZHANG ¹ ; Lanping XU ¹ ; Xiaojun HUANG ¹
Author Information

1. Peking University People's Hospital, Peking University Institute of Hematology, Department of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Xicheng District, Beijing 100044, China.
2. Peking University Health Science Center, Beijing 100191, China.
Publication Type:Journal Article
MeSH: Humans; Receptors, Chimeric Antigen; T-Lymphocytes; Precursor Cell Lymphoblastic Leukemia-Lymphoma/therapy*; Prognosis; Immunotherapy, Adoptive; Hematopoietic Stem Cell Transplantation; Receptors, Antigen, T-Cell; Recurrence
From: Chinese Medical Journal 2023;136(16):2011-2013
CountryChina
Language:English